Dongwha Pharm Rises 12.47% Amid Pharmaceutical Sector Uptrend

On the 21st, the pharmaceutical sector theme rose by 3.05% compared to the previous day, showing strength, while Dongwha Pharm, which is attracting attention as a related stock, surged by 12.47% compared to the previous day. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwalmyungsoo and Fusidin).

[Graph] Major stock price changes in the pharmaceutical sector theme

According to provisional data compiled at 11:31, foreign investors are net selling -0.20 million shares of Dongwha Pharm.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Dongwha Pharm's quant financial score is 59.6 points, with higher stability and profitability scores than the average of other pharmaceutical-related stocks, ranking 24th within the theme. This indicates that from a financial perspective, Dongwha Pharm's ability to respond to changes in domestic and international economic environments and its efficient profit-generating capability are better compared to other stocks within the theme.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of analysis by the Robo Algorithm based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.